Prosecution Insights
Last updated: April 19, 2026

Orbsen Therapeutics Limited

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18425997 SDC-2 EXOSOME COMPOSITIONS AND METHODS OF ISOLATION AND USE SPENCE, JENNIFER SUZANNE 1633 Non-Final OA Jan 29, 2024
17637737 COMPOSITIONS FOR MONOCYTE AND MACROPHAGE POLARIZATION AND METHODS OF USE ABBOTT, KODYE LEE 1634 Final Rejection Feb 23, 2022

Managing Orbsen Therapeutics Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month